JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$2.29B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.1B |
| 3 |
Vanguard Total International Bond ETF
BNDX
|
+$1.67B |
| 4 |
AbbVie
ABBV
|
+$1.6B |
| 5 |
ExxonMobil
XOM
|
+$1.5B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$3.99B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$1.15B |
| 4 |
Tesla
TSLA
|
+$1.05B |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.04% |
| 2 | Healthcare | 10.96% |
| 3 | Financials | 10.87% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4901
VSE Corp
VSEC
$6.79B
| $230K | ﹤0.01% |
4,993
-4,675
| -48% | -$233K |
|
4902
dLocal
DLO
$4.17B
| $228K | ﹤0.01% |
+7,295
| New | +$220K |
|
4903
Finance of America Companies
FOA
$201M
| $228K | ﹤0.01% |
7,501
+1,905
| +34% | +$66.4K |
|
4904
First Trust Indxx NextG ETF
NXTG
$576M
| $228K | ﹤0.01% |
3,018
+237
| +9% | +$18.2K |
|
|
SKE
4905
Skeena Resources
SKE
$4.1B
| $228K | ﹤0.01% |
20,482
+18,337
| +855% | +$206K |
|
|
SPRB
4906
Spruce Biosciences
SPRB
$151M
| $227K | ﹤0.01% |
1,512
-66
| -4% | -$12.3K |
|
4907
Citizens
CIA
$201M
| $226K | ﹤0.01% |
53,350
-49,331
| -48% | -$223K |
|
|
SBOW
4908
DELISTED
SilverBow Resources, Inc.
SBOW
| $226K | ﹤0.01% |
7,059
+5,918
| +519% | +$152K |
|
|
SMMF
4909
DELISTED
Summit Financial Group, Inc.
SMMF
| $225K | ﹤0.01% |
8,794
-10,032
| -53% | -$269K |
|
4910
IDEAYA Biosciences
IDYA
$3.49B
| $224K | ﹤0.01% |
20,058
+3,870
| +24% | +$57K |
|
4911
Ocular Therapeutix
OCUL
$2.2B
| $224K | ﹤0.01% |
45,254
+8,439
| +23% | +$46.8K |
|
|
REVG
4912
DELISTED
REV Group
REVG
| $224K | ﹤0.01% |
16,676
-16,471
| -50% | -$225K |
|
4913
InfraCap MLP ETF
AMZA
$484M
| $223K | ﹤0.01% |
7,388
+5,815
| +370% | +$170K |
|
4914
FlexShares International Quality Dividend Index Fund
IQDF
$1.17B
| $223K | ﹤0.01% |
9,346
| – | – |
|
|
SPLK
4915
PUT
DELISTED
Splunk Inc
SPLK
| $223K | ﹤0.01% |
1,500
-18,500
| -93% | -$2.27M |
|
|
FXLV
4916
DELISTED
F45 Training Holdings Inc.
FXLV
| $223K | ﹤0.01% |
20,836
-7,636
| -27% | -$98.7K |
|
4917
CorMedix
CRMD
$592M
| $221K | ﹤0.01% |
40,442
+1,968
| +5% | +$9.01K |
|
4918
Lindblad Expeditions
LIND
$2.2B
| $221K | ﹤0.01% |
14,656
+2,535
| +21% | +$40.8K |
|
|
NREF
4919
NexPoint Real Estate Finance
NREF
$319M
| $221K | ﹤0.01% |
9,798
+8,190
| +509% | +$171K |
|
|
CALA
4920
DELISTED
Calithera Biosciences, Inc
CALA
| $221K | ﹤0.01% |
27,396
| – | – |
|
4921
ACM Research
ACMR
$5.6B
| $220K | ﹤0.01% |
10,599
+1,014
| +11% | +$25.5K |
|
4922
First Business Financial Services
FBIZ
$598M
| $219K | ﹤0.01% |
6,663
+1,880
| +39% | +$60.7K |
|
4923
CALL
Humana
HUM
$46.7B
| $218K | ﹤0.01% |
500
-14,200
| -97% | -$5.94M |
|
4924
Daktronics
DAKT
$986M
| $217K | ﹤0.01% |
56,573
-22,372
| -28% | -$103K |
|
4925
Fossil Group
FOSL
$329M
| $217K | ﹤0.01% |
22,466
-101,753
| -82% | -$1.15M |
|
Similar funds
JP Morgan Chase's Q1 2022 Portfolio in Review
As of Q1 2022, JP Morgan Chase held 7,378 positions worth $830B, down 4.1% from $866B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2022 filing shows 607 new, 2,657 increased, 2,665 reduced and 679 closed positions. Its largest new stake was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M. The largest sale was Vanguard Short-Term Bond ETF, an estimated $3.99B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2022 buy was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M.
- JP Morgan Chase added most to Vanguard Total Bond Market in Q1 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q1 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $3.99B.
- JP Morgan Chase fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $442M.
- JP Morgan Chase's ten largest holdings make up 18% of its $830B portfolio in Q1 2022.
- JP Morgan Chase opened 607 new positions and closed 679 in Q1 2022.
- JP Morgan Chase's portfolio value fell 4.1% quarter-over-quarter to $830B.
Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.